Therapeutic Note(s) |
![]() |
400mg/Vial Prolong-Rel Inj Pd-Vial Pk (ARIPIPRAZOLE)
For the maintenance treatment of schizophrenia in patients who are stabilized on oral aripiprazole who have:
A history of non-adherence; AND one of the following:
a) Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; OR
b) Inadequate control or significant side-effects from one or more conventional depot antipsychotic agents.